SS-31 vs 5-Amino-1MQ: Mechanism, Half-Life & Research Use

When evaluating mitochondrial modulators and metabolic regulators in preclinical research models, selecting the appropriate compound is critical for experimental fidelity. This comparative guide contrasts SS-31 (Elamipretide), a cardiolipin-targeted mitochondrial peptide, against 5-Amino-1MQ, a small-molecule nicotinamide N-methyltransferase (NNMT) inhibitor. Explore their biochemical pathways, half-lives, solubility profiles, and laboratory applications to optimize your experimental design.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

When evaluating mitochondrial modulators and metabolic regulators in preclinical research models, selecting the appropriate compound is critical for experimental fidelity. This comparative guide contrasts SS-31 (Elamipretide), a cardiolipin-targeted mitochondrial peptide, against 5-Amino-1MQ, a small-molecule nicotinamide N-methyltransferase (NNMT) inhibitor. Explore their biochemical pathways, half-lives, solubility profiles, and laboratory applications to optimize your experimental design.

Reviewed by PX1 Research scientific team

Key takeaways

  • [SS-31](/research-peptides/ss-31) and [5-Amino-1MQ](/research-peptides/5-amino-1mq) target distinct pathways within cellular bioenergetics.
  • To assist laboratory personnel in selecting the appropriate analytical reference standard, the following criteria table summarizes the physical, structural, and operational parameters of both research compounds:
  • [SS-31](/research-peptides/ss-31) (D-Arg-Dmt-Lys-Phe-NH2) belongs to the aromatic-cationic class of mitochondrial-targeted peptides.
  • [5-Amino-1MQ](/research-peptides/5-amino-1mq) operates through a completely distinct enzymatic pathway.

Comparative Overview: Direct Answer & Key Differences

SS-31 and 5-Amino-1MQ target distinct pathways within cellular bioenergetics. SS-31 is a synthetic tetrapeptide that selectively binds cardiolipin in the inner mitochondrial membrane, mitigating reactive oxygen species (ROS) and stabilizing ATP synthesis. Conversely, 5-Amino-1MQ is a small-molecule NNMT inhibitor that elevates intracellular NAD+ levels and promotes fat-metabolism signaling in metabolic models.

While both compounds are widely studied in models of metabolic dysfunction and bioenergetic decay, their molecular targets dictate fundamentally different experimental applications. Researchers investigating structural mitochondrial integrity, electron transport chain (ETC) coupling, or ischemia-reperfusion injury frequently utilize SS-31. In contrast, investigators focused on nicotinamide adenine dinucleotide (NAD+) salvage pathways, adipocyte hypertrophy, and systemic energy expenditure rely on 5-Amino-1MQ. Understanding these mechanistic divergences is essential for constructing rigorous in vitro and in vivo protocols.

Structural and Biochemical Specifications

To assist laboratory personnel in selecting the appropriate analytical reference standard, the following criteria table summarizes the physical, structural, and operational parameters of both research compounds:

| Criterion | SS-31 (Elamipretide) | 5-Amino-1MQ | | :--- | :--- | :--- | | **Molecular Class** | Synthetic Aromatic-Cationic Tetrapeptide | Quinoline Derivative (Small Molecule) | | **Primary Mechanism** | Binds cardiolipin; stabilizes inner mitochondrial membrane | Inhibits nicotinamide N-methyltransferase (NNMT) | | **Primary Target** | Inner mitochondrial membrane (IMM) / Cardiolipin | NNMT enzyme (cytosolic / nuclear) | | **Downstream Effects** | Reduces mitochondrial ROS, preserves ATP output | Raises NAD+ levels, enhances lipid oxidation | | **Reported Half-Life** | ~2–4 hours (plasma, rodent models) | ~4–6 hours (in vitro / microsomal stability) | | **Solubility Profile** | Highly water-soluble; reconstitutes in sterile water or PBS | Soluble in organic solvents (DMSO, Ethanol); sparingly soluble in water | | **Typical Preclinical Model** | Ischemia-reperfusion, age-related mitochondrial decay | High-fat diet induced obesity, muscle regeneration | | **Available Formats** | Lyophilized peptide powder | High-purity crystalline research powder |

Both compounds are supplied exclusively for laboratory research use only and must be handled under controlled analytical conditions by qualified investigators.

Biochemical Mechanism of SS-31: Cardiolipin Stabilization

SS-31 (D-Arg-Dmt-Lys-Phe-NH2) belongs to the aromatic-cationic class of mitochondrial-targeted peptides. Its core biochemical mechanism centers on its high affinity for cardiolipin, an essential phospholipid localized exclusively to the inner mitochondrial membrane. Cardiolipin is critical for anchoring electron transport chain complexes, maintaining membrane curvature, and regulating the opening of the mitochondrial permeability transition pore (mPTP).

In vitro data indicate that under conditions of oxidative stress, cardiolipin undergoes peroxidation, destabilizing supercomplex organization and causing excessive electron leakage (ROS production). Preclinical studies suggest that SS-31 selectively interacts with cardiolipin through electrostatic and hydrophobic interactions, preventing ROS generation at Complex I and Complex III. By maintaining cardiolipin structural integrity, SS-31 preserves membrane potential (ΔΨm), sustains ATP production, and prevents cytochrome c release, making it a pivotal tool in bioenergetic research.

Biochemical Mechanism of 5-Amino-1MQ: NNMT Inhibition & NAD+ Dynamics

5-Amino-1MQ operates through a completely distinct enzymatic pathway. As a membrane-permeable small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), 5-Amino-1MQ targets an enzyme upregulated in adipose tissue, liver, and specific tumor cell lines during metabolic dysfunction.

NNMT catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide (NAM), producing 1-methylnicotinamide (1-MNA). This reaction irreversibly depletes the cellular pool of nicotinamide, preventing its recycling through the NAD+ salvage pathway. Preclinical literature demonstrates that inhibiting NNMT with 5-Amino-1MQ suppresses 1-MNA production, thereby conserving intracellular NAD+ pools and elevating S-adenosylmethionine (SAM) availability. Consequently, in vitro and animal models show increased cellular energy expenditure, enhanced mitochondrial output, and activated fat-metabolism signaling pathways without altering food intake.

Preclinical Literature Review: SS-31 in Oxidative and Ischemic Models

The preclinical footprint for SS-31 spans over two decades of cardiovascular, renal, and neuromuscular research. In rodent models of renal ischemia-reperfusion injury, administration of SS-31 prior to or during reperfusion significantly attenuated tubular necrosis, microvascular congestion, and inflammatory cytokine surge. Investigators attributed these outcomes directly to the preservation of mitochondrial cristae structure.

Similarly, in animal models of age-related cardiac dysfunction, prolonged SS-31 exposure demonstrated a reversal of diastolic dysfunction and a reduction in myocardial fibrosis. In skeletal muscle studies involving aged mice, short-term SS-31 treatment rapidly restored in vivo mitochondrial ATP synthesis capacity and improved muscle endurance, demonstrating that functional bioenergetic deficits can be rapidly ameliorated by targeted cardiolipin protection.

Preclinical Literature Review: 5-Amino-1MQ in Obesity and Metabolic Research

Research surrounding 5-Amino-1MQ has grown rapidly in the context of metabolic disease, adipogenesis, and cellular aging. In high-fat diet-induced obese mice models, treatment with 5-Amino-1MQ produced a marked reduction in adipocyte volume and overall body mass, primarily driven by enhanced basal metabolic rate and lipolysis within white adipose tissue.

Furthermore, in vitro assays involving cultured myoblasts demonstrate that NNMT inhibition via 5-Amino-1MQ supports muscle cell proliferation and differentiation following injury models. By preserving the intracellular ratio of NAD+/NADH, 5-Amino-1MQ activates sirtuin pathways (particularly SIRT1), leading to downstream mitochondrial biogenesis via PGC-1α upregulation. These findings make 5-Amino-1MQ a primary candidate for investigations into metabolic flexibility and age-related tissue degradation.

Comparative Analysis: SS-31 vs 5-Amino-1MQ vs Related Metabolic Modulators

When designing mitochondrial or metabolic experiments, researchers often evaluate SS-31 and 5-Amino-1MQ alongside other mitochondrial-derived peptides and metabolic modulators. For instance, mitochondrial-derived peptides like MOTS-c regulate metabolic homeostasis by targeting the folate cycle and promoting AMPK phosphorylation, whereas Humanin acts primarily as a cytoprotective factor that blocks apoptosis under stress conditions.

While SS-31 directly restores inner membrane architecture and 5-Amino-1MQ alters cytosolic NAD+ salvage enzyme kinetics, compounds like MOTS-c act as nuclear-signaling messengers during metabolic stress. Comparing these distinct classes allows researchers to construct multi-targeted in vitro protocols to interrogate complementary aspects of cellular energy control. To explore additional compounds across this research vertical, consult the complete PX1 catalog of research peptides.

Selecting the Optimal Compound for Laboratory Study Designs

Choosing between SS-31 and 5-Amino-1MQ depends strictly on the primary hypothesis and experimental endpoints of your study:

- **Select SS-31 if your research focuses on:** Structural mitochondrial damage, cardiolipin oxidation, ischemia-reperfusion models, acute oxidative stress, or preserve electron transport chain coupling in isolated mitochondria. - **Select 5-Amino-1MQ if your research focuses on:** NNMT enzymatic kinetics, NAD+ salvage pathways, lipid accumulation in adipocyte cultures, systemic energy expenditure, or metabolic signaling in obesity models.

For comprehensive technical literature, methodological guides, and comparative whitepapers, visit the PX1 research library.

Solubility, Handling, and Reconstitution Protocols

Proper laboratory preparation is essential to maintain structural integrity and prevent batch degradation. SS-31 is highly hydrophilic and readily dissolves in sterile water, normal saline, or phosphate-buffered saline (PBS, pH 7.4). For precise molar calculation during assay preparation, researchers should utilize our interactive reconstitution calculator to determine appropriate diluent volumes.

Conversely, 5-Amino-1MQ is hydrophobic and requires stock solution preparation in organic solvents such as dimethyl sulfoxide (DMSO) or ethanol prior to dilution into aqueous assay buffers. Working solutions should be prepared immediately before experiment execution, and freeze-thaw cycles must be strictly minimized. Store lyophilized or dry powders at -20°C in desiccated storage cabinets.

PX1 Research Quality Assurance & Analytical Standards

PX1 Research maintains rigorous quality assurance protocols to guarantee that all reference compounds meet exacting scientific standards. Every lot of SS-31 and 5-Amino-1MQ manufactured in our USA-based facilities undergoes thorough chemical characterization.

Purity is independently verified via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) within ISO 17025 accredited analytical laboratories, ensuring chemical purity exceeding 99%. Additionally, all batches are subjected to Limulus Amebocyte Lysate (LAL) testing to ensure strict endotoxin limits are maintained for sensitive cell culture and in vivo applications. Researchers can review batch-specific test results by accessing our public Certificate of Analysis (COA) portal. Orders placed Monday through Friday ship same-day from our California and Arizona fulfillment centers. For institutional bulk procurement and custom laboratory accounts, please consult our wholesale portal.

Frequently Asked Questions

What is the fundamental difference between SS-31 and 5-Amino-1MQ?

SS-31 is a cardiolipin-targeted tetrapeptide that stabilizes the inner mitochondrial membrane and reduces ROS. 5-Amino-1MQ is a small-molecule enzyme inhibitor that blocks NNMT, preserving NAD+ pools and promoting lipid metabolism.

Is 5-Amino-1MQ classified as a peptide?

No, 5-Amino-1MQ is a synthetic small-molecule quinoline derivative that acts as an enzymatic inhibitor. It does not possess peptide bonds or amino acid sequences like SS-31.

What solvent should be used to reconstitute 5-Amino-1MQ for cell culture?

Due to its hydrophobic nature, 5-Amino-1MQ should first be dissolved in high-purity DMSO or ethanol to create a concentrated stock solution before diluting into aqueous cell culture media.

How does PX1 Research verify compound purity?

PX1 Research verifies compound purity through independent ISO 17025 accredited laboratory testing using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). Batch-specific COAs are downloadable directly from our site.

Are SS-31 and 5-Amino-1MQ stable at room temperature?

While stable during short-term transit, both dry lyophilized powders should be stored at -20°C upon receipt in a desiccated environment to prevent moisture contamination and degradation.

How does 5-Amino-1MQ elevate intracellular NAD+ levels?

By inhibiting the enzyme nicotinamide N-methyltransferase (NNMT), 5-Amino-1MQ blocks the conversion of nicotinamide to 1-MNA, allowing nicotinamide to remain available for the NAD+ salvage pathway.

What are the endotoxin specifications for PX1 research compounds?

All PX1 Research compounds are tested via LAL assay to confirm endotoxin levels meet strict laboratory standards (typically <0.1 EU/mg), ensuring compatibility with sensitive in vitro assays and animal models.

Are these compounds approved for human clinical use or consumption?

No. All products provided by PX1 Research are strictly for laboratory research use only by qualified scientific personnel. They are not intended for human or veterinary administration, therapy, or diagnosis.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.